Literature DB >> 2523966

Decreased disability rate among 3-year-old survivors weighing 501 to 1000 grams at birth and born to residents of a geographically defined region from 1981 to 1984 compared with 1977 to 1980.

S Saigal1, P Rosenbaum, B Hattersley, R Milner.   

Abstract

In this article we report the survival and morbidity rates for all live-born infants weighing 501 to 1000 gram at birth and born to residents of a defined geographic region from 1977 to 1980 (n = 255) compared with 1981 to 1984 (n = 266). During these periods, there were no changes in the proportion of infants delivered at the tertiary care center or community hospitals (171/84 vs 194/72); use of the tertiary care center increased only slightly, from 84% to 91%; and changes in neonatal management were mainly in improvements in diagnostic and monitoring techniques. When infants were grouped according to birth weights in 100 gm increments, survival improved significantly only for infants weighing between 501 and 600 gm at birth (2% vs 20% p less than 0.001). There were no differences in the overall survival rates to hospital discharge (46% vs 48%). The prevalence of neurosensory impairments was 24% in period 1 and 17% in period 2. There was a significant improvement in the proportion of infants considered to have disabilities by a functional classification assigned at 3 years corrected age (50% vs 27%, p less than 0.001), but only for infants weighing more than 800 gm at birth (49% vs 22%, p less than 0.001). Infants delivered at the community hospitals had a higher prevalence of neurosensory impairments compared with infants delivered at the tertiary care center (period 1, 35% vs 21%, not significant; period 2, 37% vs 14%, p less than 0.05). These data are encouraging; further efforts should be directed toward assessing which, if any, components of perinatal care are contributing to the improvement in morbidity rates.

Entities:  

Mesh:

Year:  1989        PMID: 2523966     DOI: 10.1016/s0022-3476(89)80150-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  20 in total

1.  The Scottish low birthweight study: I. Survival, growth, neuromotor and sensory impairment.

Authors: 
Journal:  Arch Dis Child       Date:  1992-06       Impact factor: 3.791

2.  Dangerous economics: resource allocation in the NICU.

Authors:  J A Zupancic
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

Review 3.  Establishing neonatal networks: the reality.

Authors:  Neil Marlow; A Bryan Gill
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-12-11       Impact factor: 5.747

4.  Neonatal follow-up programs and follow-up studies: Historical and current perspectives.

Authors:  Reg Sauve; Shoo K Lee
Journal:  Paediatr Child Health       Date:  2006-05       Impact factor: 2.253

5.  Predicting death from initial disease severity in very low birthweight infants: a method for comparing the performance of neonatal units.

Authors:  W Tarnow-Mordi; S Ogston; A R Wilkinson; E Reid; J Gregory; M Saeed; R Wilkie
Journal:  BMJ       Date:  1990-06-23

6.  Neonatal personnel in Canada.

Authors:  D McMillan; T Perreault; M Watanabe; G Chance; D F Askin; J Hall
Journal:  Paediatr Child Health       Date:  1997-05       Impact factor: 2.253

7.  Functional abilities at age 4 years of children born before 29 weeks of gestation.

Authors:  A Johnson; P Townshend; P Yudkin; D Bull; A R Wilkinson
Journal:  BMJ       Date:  1993-06-26

8.  Enhanced roles for health professionals in newborn care.

Authors: 
Journal:  Paediatr Child Health       Date:  2000-03       Impact factor: 2.253

9.  Neurodevelopmental outcome after neonatal extracorporeal membrane oxygenation.

Authors:  C M Robertson; N N Finer; R S Sauve; M F Whitfield; T K Belgaumkar; A R Synnes; M G Grace
Journal:  CMAJ       Date:  1995-06-15       Impact factor: 8.262

Review 10.  Cerebral palsy--an increasing contributor to severe mental retardation?

Authors:  A Nicholson; E Alberman
Journal:  Arch Dis Child       Date:  1992-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.